Clinical Trial

A Phase I Study of Single and Multiple Doses of HS-20136-2 Injection in Healthy or Obese Participants

Not Yet Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
The study is being conducted to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of single and multiple doses of HS-20136-2 injection in healthy/obese participants.
Trial Details
NCT Number NCT07716241
Lead Sponsor Jiangsu Hansoh Pharmaceutical Co., Ltd.
Conditions Obesity
Enrollment 92 participants
Start Date 2026-09-22
Primary Completion 2027-05-14 (estimated)
Study Completion 2027-05-14 (estimated)
Updated on ClinicalTrials.gov 2026-07-21